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Liver Transplantation 
THERE .\RE two kinds of liver transplantations. In one (FiJ!; 
-to-I), an extra organ is placed in an ectopic site (usually the 
right paravertebral gutter) and arterialized from a rcgional ves-
sel, such as the distal aorta. The grafts need the so-called hepa-
totrophic factors in splanchnic venous blood,2.'1 and thus an cffort 
is made to provide portal venous inflow from the splanchnic sys-
tem (see Fig -to-1). \'enous outflow is arranged by anastomosing 
the graft vena cava to the recipient vena cava. Only two of 100 
patients treated with this pf(x:edure throughout the world have 
had long survival;2. 3 One of these recipients was a child. 2 
The most ent'Ouraging results have been with the se<"olld ap-
proach. orthotopic transplantation (liver replat-ement), whereby 
the diseased organ is removed and replaced with a graft placed 
in the evacuated hepatic fossa. The blood \"l'ssels ,trc rCCOI 
llt.'ded in as normal a way as possible. ilnd prm'isions arc mad 
for hiliary drainage (Fig -40-2), This chapter \\ill be coneenl(' 
,,;th the orthotopic operation. 
The Laboratory Origins 
:\s with other organs, the central problt'lll afil'r li\·t'r transp\;\! 
tation has been the prevention of rejeetion. In IIl1trl'ated do!!' 
rejection begins in 3 or .. days. On histopathologi<.- l'xaminatiOl 
mononuclear cells infiltrate the entire graft. but especially in tic 
periportal and central areas of the liver lobules. ~lassive necros 
e"entually occurs. Prevention of this prot-ess of rejection h, 
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FIg 4O-1.-Auxiliary liver transplantation, Note that the transplant was given 
a double blood supply and that the venous component was from the non hepatic 
splanchnic bed. Outflow was into the inferior vena cava, Auxiliary transplantation 
has been abandoned, G,b. indicates gallbladder: S,m,v .. superior mesenteric 
vein: and I,v,c .. inferior vena cava, (Used by permission, ") 
been a central objective of our efforts for more than a quarter of 
a century, as rel1llmted in Chapter 31'1, 
~1Mre than :20 years ago, a mongrel dog became the first 
chronic suryh'or after liver replacement, thanks to the drug aza-
thioprine, which had just been introduced into t1inical medi-
cine, 14.21 The dog lived for almost 12 years, most of this time off 
therapy, demonstrating the feasibility of chronic sUf\'ival after 
liver transplantation, The feat of preventing rejection in dogs was 
repeated many times in 196414,11 and subsequently,I<. 11 The lah-
oratory SUCl"esses prompted c1ink-dl trials, 14, 2.1, O~ 
The Pace of Oinical Trials 
Nevertheless, the first seven attempts at clinical transplanta-
tion in three different institutions were failures, f~I 23, 2< It was not 
until 1967 that the first prolonged survival of a human recipient 
for more than a year was obtained. 16 That first child subsequently 
died of metastases from the hepatoma for which she had been 
treated, In January 1970, a child with biliary atresia and an in-
cidental hepatoma was given a new liver. She is now more than 
14 years post-transplantation, the longest survival yet achieved. 
Over the years, an increasing number of chronic SUf\'ivors have 
been reported by us, 19,20 by Caine I and Rolles et al. II of Eng-
land, from Holland, ij from two centers in Germany, 10. 28 and from 
France, Canada, and Chin,'_ In the United States, li"er trans-
plantation programs are active at our university (Pittsburgh) and 
at the universities of Tennessee, ~1innesotaI Haf\'ard, and Cali-
fornia. Many more are planned. 
Until 1980, the first year cyclosporine was available, at the 
University of Colorado we performed between ten and 20 liver 
transplants per year, In 19.'H, at thc l'ni"crsity of Pittsburgh 
where our pro)!ram was transferred, :)0 livcr transplantations 
wcre performt,(i. In 1 yg~OK the nlllnhcr was increasl'd to 80 f~r 
,'ear, and in 19S3 the ;1II11l1d1 nUlllhcr was 104 (Fig ,to-3). In tIll' 
first:) months of 19'H, :j., tral"plantatiolls were pedilnlled at a 
pacc that, if t~lfftinlitDlfK \\ill ,'ield a \'('arly total of nearly 150. 
During the 4 y,'ars ,illn' t',eiosporin(' was intnKlllced. :2f1h 
tl~lflsplantations han' 1N.'<'u lX'riiH'mt'd, compared with the 192 in 
t hc prccedill)! 17 years, Ollr I!;rand tntal of orthotopic livcr trans-
plantations hy the end of \Iard. 19"4 had reachl,d 458 ill 377 
recipicnts, Hetransplantation. a rl'lath'ch- eas" ulldertaking, par-
ticularl" if the first I!rJ,ft I'lils ca.-h-, has h"l'n done 81 times, 
Of tl;e 377 patients trt'ated "'iih li"cr transplantation through 
\Iarch 191)4, 169 E4R~D were in thc pcdiatric age category (less 
than 18 years). The following remarks will emphasize this pedi-
atric portion of our total t"lwril'nt'c, 
Indications for Liver Transplantation 
BILlAtly ATlu:sl.\,-Patients "'ith hiliary atresia or hypophtsia 
al'counted for 9-! of till' 169 total pediatric liver recipients (Table 
40-1), Although hepatit' portol'nterostom" is the first operation 
to he pcrforllwd for dlildren with hiliary atresia. 7 many such 
procedures are unsul'l., .. "ful. Il'a"ing Iwpatic transplantation as 
the only option. The U>l' of lin'r transplantation in infants and 
children sometimes hoi' l ... ·cn questioned hecause of the unsatis-
factorv sUf\'h'ai and hidl lI1orhidih', byDt~n after "su<:cessful" 
trdnsl;lantatioll. tlte '1l1ali!\ of lift' h;ls too often been deJ!;r.lded 
hv the side effects of high-dose corticosteroid therapy. That sit-
uation has chanJ!;ed sinn' the use of cydosporine-eortkosteroid 
therapy. 17, 2n 
The decision about candidac,' in patients with biliary atresia 
and failed portoenterostomy is easy, In the past, these little vi<'-
tims have become pariahs of nature with a massive social, medi-
cal, and economic input. but with little meaningful ultimate ben-
efit for themselves or their families, The s\'nthetic function of the 
liver frequently is relath'e!,' good until sl;ortlv before death. Al-
though these <:'hildren aJways ha\'e had a pre"ious operation. the 
technical diflil'ulties at transplantation are only moderate, TIle 
most serious technk-al prohlems ha,'e been caused by anomalies 
of the portal \ein or hepatic 'lrtery, 1<.211 There is no threat of 
disease recurrenl't', 
I:-IBOtIN ERRORS OF yfbqyBlilp~fK-qhe second largest recipi-
ent group has been made lip of children with se"eral inborn er-
rors of metabolism tsee Table 40-1), induding alpha-I-antitryp-
sin deficienl'y disease, \\'i\son's disease, tyrosinemia, glycogen 
TABLE -W-l.-hDtC.\TlO'\s FOR LIYER TRA:\SPLA:'Io'T,\TIO'\ 
IN PEDI.HRIC P,HIENTS S 18 YE.\RS 
PRE-CYCLOSPORI:\E ERA 
,'.Iarch I, 1963-
F ehman' 29. 1980) 
~fAf" I:\Dtc.\no:,\ "0, 'Patients 
Biliary atresia 51 
fnbo~ metabolic errors 13 
Nonalcoholic cirrhosis 13 
Primary liver malignant,,' 3 
»I eonatal hepatitis 2 
Congenital hepatic fibrosis 2 
SecondarY bilian' cirroo,;is· 2 
Bvler's disease ' 0 
B~dd-Chiari syndrome 0 
Inflammatory Pseudotumor 0 
Suhacute hepatitis 0 
Total 86 
*Trauma or dlOledochaJ cyst, 
CYCLOSPORI:"\E ER\ 
(March 1. 1950-
~farch 31. 19&4) 
No, Patients 
43 
21 
-; 
o 
:2 
5 
1 
I 
1 
63 
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/ ('_' 
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Fig 4o-2.-Completed orthotopic liver transplantation, A, biliary tract reconstruction with choIedochocholedochostomy, B, biliary tract 
reconstruction with choledochojejunostomy. using a Roux limb. (Used by permissionK~ 
storage diseases (GSD). the sea-blue histiocyte syndrome, and 
homozygous type 2 hypercholesterolemia (FH) (Table 40-2). A 
6-,'ear-old child with familial hypercholesterolemia also had her 
heart replaced at the same operation because of coronary artery 
and valvular disease, after two coronary b,'pass procedures and a 
,"ake replacement. 
With the possible exception of the sea-blue histiocyte syn-
drome, the inborn metabolic abnormalities listed in Table 40-2 
were cured or palliated by sllccessful lin'r transplantation. The 
child with sea-blue histiocyte syndrome i\\"hic:h is a lipid storage 
disorder of unknown cause) had a pro~ressiy"e and very serious 
Number of grafts 
neurologic syndrome that was arrested but not reversed after 
successful liver transplantation. A liver biopsy of this patient 1 
year postoperatively showed moderate disposition of lipid drop-
lets. Although she is now more than 2 years postoperative, we 
do not believe that her basic problem has been corrected, 
In contrast, patients ",;th alpha-i-antitrypsin deficiency as-
sume the protease inhibitor (Pi) type of their donors, and the 
low serum values of the alpha globulin are promptly and per-
manently restored to nonnaL The abnormal amino acid patterns 
of tyrosinemia are rectified within hours. The same holds true 
for the aberrations caused by glycogen storage diseases, as ex-
fflr---------------------------------------------~ 
100 
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60 t-
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70 r 
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m SeconO grafts 
• F lrst grafts 
Fig ~_-lr1hotopic liver transplantations at the University of Colorado 
(1963-1980) and the University of Pi"sburgh (1981-1983): Number of liver 
Year 
grafts implanted per calendar year, Note the increasing numbers of second and 
third transplantations, 
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TABLE 40-2.-INBoRs ~fbqAUMfKlC ERRORS TIIEATED WITH 
LIVER TRANSPLASTATIOS IS PEDJ.HHIC PATIESTS $ 18 yE .... RS 
l'IIE·CYCf.OSI'OIlI"E ERA 
(\larcb I, 196.1-
Fehruarv 29, 1980) 
CYCI.OSPORI"E ER.\ 
(\Iarch 1. 1980-
March 31. 1984) 
DIAGNOSIS No: Patients :'110. Patients 
Alpha-I-antitrypsin 9 13 
de6ciency disease 
Wilson's di~ease ;2 :3 
;2 Tyrosinemia 1 
Glycogen storage disease 1 
Sea-blue histiocyte svndrome 0 
Homozygous fa;"ilial 0 
hypercholesterolemia 
Total 13 21 
emplified by a patient with type 1 GSD who became able to fast 
for 1 or 2 days \\;thout the h4'poglycemia that previously oc-
curred within hours (Fig 40-4). 
Some of these metabolic diseases are known to be caused bv 
specific enzyme deficiencies. The pathogenesis of other diso~­
deI'S, such as \\'ilson's disease, has not been understood. This 
state of knowledge has not influenced the effectiveness of the 
"biochemical engineering" by organ transplantation in Wilson's 
disease, and it is now obvious that disease recurrence after liver 
transplantation need not be feared. Figure 40-5 depicts the 
course of a child with Wilson's disease who had liver transplan-
tation more than 13 years ago. After operation, the serum ceru-
loplasmin rose from zero to normal levels. There was a massive 
decoppering process by copper excretion in the urine and prob-
ably feces, during which time Kayser-Fleischer rings disap-
~ 
o 
E 
;;; 
... 
o 
Fig 4O-4.-Response of blood glucose to fasting in a ~ 
patient with type 1 glycogen storage disease before and ~ 
after liver transplantation. (Used by permission . ., 0 
1 
5 
6p 
peared. as shown by slit-lamp examination, and severe neuro-
logic abnormalities were reversed. 
The 6-vear-oJd child \\;th familial hypercholesterolemia whose 
heart and liver were replaced had a striking fall of serum choles-
terol concentration from 1.000 mg% to new levels averaging 300 
mg%. It is probable that the correction is incomplete. because 
the normal serum cholesterol in children of this age is about 150 
mg%.15 
CHROSIC AcrI\'E HEP\TITIS.-The third leading indication for 
liver replacement in children has been chronic acti\'e hepatitis 
(nonalcoholic cirrhosis) lsee Table 40-1). Twenty of our 169 
childhood recipients had this diagnosis. Decisions about candi-
dacy became relatively easy, once it was realized that no patient 
accepted as a candidate (for whom a liver could not be promptly 
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Flg 40-5.-Treatment with orthotopic liver transplantation in a 16-year-old 
boy with Wilson's disease. The operation was on March 23, 1971, and the patient 
is still alive, Note the massive urinary copper excretion postoperatively and the 
increase of serum ceruloplasmin to normal levels. The recipient's neurologic find-
ings reversed slowly over a 2-year period, during which regression of Kayser-
found) lived for more than a few months. These patients present 
many problems in management. Some ha\'e had a portacaval 
shunt or other operation in the hepatic hilum. Their metabolic 
abnormalities when first seen often ha\'e been profound, and the 
removal of their small shrunken liver sometimes has presented 
extraordinary technical difficulties. Such patients have accounted 
for the legendary marathon operations of liver transplantation 
\\;th the loss of dozens of units of blood. 
In adults carrying the hepatitis B \'irus, disease recurrence has 
been a problem, recapitulation of the original disease occurring 
in the grafts. 20 Such carriers have been responsible for hepatitis 
among the staff. Recurrent chronic acth'e hepatitis has not yet 
been encountered in children. 
LESS Cl!fKf~flk fkalCAqfl~sK-lther indications for liver 
transplantations in children are listed in Table -to-I. Many ef-
forts have been made to treat unresectable primary hepatic ma-
lignancies. Most of this experience has been with adults. but a 
few children have been included (see Table 40-l). It was first 
thought that decision of candidacy was an easy m'ltter, but tumor 
recurrence in our early experience was as high as 85%.4. 20 \\'e 
now believe that with better case selections, disease recurrence 
can be much less, although this has not been verified in children. 
\lost patients with hepatic malignancies do not have overt liver 
failure. More than 90% have had previous operations, but the 
technical difficulties have not been great. 
Surgical Technique 
The Donor Operation 
Having emphasized that the difficulty of transplantation is dic-
tated largely by the original disease and previous operations, we 
tum now to some surgical details, beginning with the donor op-
eration. The principles of liver removal, methods of hepatic pres-
MONTHS 
Fleischer rings was documented by ophthalmoscopic examination. Immuno-
suppression was with cyclophosphamide (or azathioprine, used interchangeably). 
prednisone. and antilymphocyte globulin. (SGPT = serum glutamic pyrwic 
transaminase). 
ervation, and the relation of total hepatectomy to extirpation of 
other grafts in the same donor were discussed in Chapter 38. 
Livers that are preserved with the potassium-rich Collins' solu-
tion before placing them in ice slush can be safely preserved for 
at least 6-8 hours, long enough to allow transport of the organs 
to the transplant center from any part of the United States. We 
have accepted livers in Pittsburgh from the East, West, and 
South coasts and from Canada. Livers have been successfullv 
preserved for 11 or 12 hours on at least ten occasions. Simila:r 
logistic links exist in Europe, supplying livers to the English. 
Dutch, and German centers. 
In infants and children whose livers are being obtained for 
grafting, it is often advisable to keep the celiac axis in continuity 
with the upper abdominal and thoracic aorta. The donor thoracic 
aorta can be turned down 180 degrees for anastomosis to the 
recipient's lower abdominal aorta (Fig 40-6). The use of the aor-
tic anastomotic technique is particularly valuable when the liver 
graft receives part of its blood supply from the superior mesen-
teric artery, in which case the blood from both the celiac axis 
and the superior mesenteric arteries can be channeled into the 
liver "ith the single aortic anastomosis. 13. 1~ 
The Recipient Incision 
In infants and young children, a bilateral subcostal or trans-
verse upper alxlominal incision, often using the previous inci-
sion, almost always gives adequate exposure. Recipient hepatec-
tomy in children is generally easier than in adults. 
The Vascular Anastomoses 
The anastomoses (particularly of the artery and portal vein) 
and biliary reconstruction are more difficult and require more 
technical skill in children than in adults. 
Transplantation begins with the vena cava anastomoses above 
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Fig 4~K -The use of the aorta in continuity with the hepatic artery for anas-
tomosis to the recipient aorta. (Used by permission.'3) 
and below the liver. If the air entrapped in the graft is not 
washed out (Fig 40-7), bubbles that are released into the circu-
lation can pass by right-to-left shunts, characteristically well de-
veloped in liver disease, to the systemic circulation and then pass 
to the brain. 26 The cold saline or lactated Ringer's solution, 
which is used for a final flush (Fig 40-7), washes out the potas-
sium-rich preservation fluid from the liver before the circulation 
is opened. 
If all goes quickly, the portal venous and arterial anastomoses 
are performed before blood is allowed to circulate through the 
liver. Otherwise, the portal circulation should be reopened first, 
allowing partial perfusion of the liver while the arterial anasto-
mosis is being performed. Every effort is made to restore a par-
tial or complete blood supply within 60 minutes of removing the 
graft from the refrigeration chamber. 
We employ a continuous suture of monofilament polypropyl-
ene (Prolene) for all vascular anastomoses. To avoid purse-stringing, 
excessive traction on the continuous sutures is avoided. Half of 
the circumference is completed with each end of an original cor-
ner suture. The knots for the portal vein and hepatic artery anas-
tomoses are placed away from the vessel wall in order to leave 
extra Prolene that slowly works its way back into the suture line 
(Fig 40-8). This "growth factor" technique IS is an important 
means of eliminating strictures in the small-caliber anastomoses 
that must be constructed during liver transplantation in children. 
Biliary Tract Reconstruction 
The ideal form of biliary duct reconstruction is a choledocho-
choledochostomy with aT-tube stent (see Fig 4O-2,A), but in 
patients with biliary atresia, that option does not exist. Cholecys-
toenterostomy, which depends upon bile drainage through the 
Sup,ohe pat.e onollOmo ••• 
A. 
Low ....... culo' ... itht 
.s.1t.1CaIfI 
c. 
Fig 4O-7.-Methocl of portal infusion to flush out potassium-rich pr8S8IVation 
fluid and air bubbles at the time of the liver insertion. G.b. indicates gallbladder: 
c.d .. common duct; Lv.c •• inferior vena cava; p.v .. portal vein; and h.a., hepatic 
artery. (Used with permission."") 
cystic duct, is not used because of the high incidence of subse-
quent obstruction of the cystic duct.2O End-to-side anastomasis 
of graft common duct to a Roux-en-Y loop of jejunum \\;th an 
internal stent (choledochojejunostomy) has been the reconstruc-
tion of choice in cases of biliary atresia and for other disorders in 
which the recipient common' duct is inadequate (see Fig 40-
2,8). Choledochojejunostomy has proven to be one of the most 
satisfactorY of all the methods of biliar.· reconstruction.; [\'en 
the small ~mmon ducts of liver obtained from infant donors c-an 
be satisfactorily anastomosed to the intestine. 
In patients ~th biliary atresia, the Rom: limb previously ('On-
structed for hepatic portoenterostomy can be reused at the time 
of liver transplantation, pro\iding the limb has not been irrepar-
ably damaged in the hilar dissection during recipient hepatec-
tomy. The risk of Roux limb injury has been particularly great 
when_an external jejunostomy was used with the Kasai proce-
dure,' in hope of decreasing cholangitis. Even if the ostomy has 
been closed by the time of transplantation, this portion of the 
Roux limb frequently has had to be resected, often "ith great 
difficultv . 
Caln~l has recommended a procedure for biliary tract recon-
struction that was originally described by Waddell and Gro\·er."-
The donor common duct is anastomosed to the gallbladder. and 
the tip of the gallbladder is anastomosed to the intestine or to 
the recipient common duct. We rarely use this operation and 
limit its use to cases in which extra length is needed to bridge a 
gap between the donor ducts and recipient intestine. -
Immunosuppr;sswn and Survival 
As was summarized in ~t~PUI the immunosuppression 
used to prevent rejection of hepatic grafts was developed \\ith 
,.." 
,IG. Z 
Fig 40-8.-"Growth factor" technique used with continuous Prolene suture 01 
small vessels. Note that anastomosis of half the circumference of the vessels is 
pertormed WIth each half of the original suture. Where the two halves meet. the 
q,ot IS tied at a conSiderable distance aw~ from the vessel wall. providing an 
excess of Prolene that is secondarily drawn into the suture line. (Used by per-
miSSIon. ,.) 
the f.u simpler clinical model of renal transplantation. The main 
rt'giJllel1s developed in renal transplantation are summarized in 
Table 38-1. The "modem era" of transplantation began with the 
,o-cllled double-drug treatment with azathioprine plus predni-
,one. When antilymphocyte globulin (ALG) was used to poten-
tiate the effectiveness of azathioprine and prednisone. the regi-
men became known as triple-drug therapy. 
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Fig 40-9.-The actual survival curve of 170 consecutive patients (children 
and adults pooled) treated with conventional immunosuppression vs. the actuar· 
ial survival (minimum survival is 6 months) 01 the first 170 patients treated with 
cydosporine and steroids. 
Immunosuppression and Suroival 379 
100 1963-1979 on 1 - 170 
Children __ N = 86 
.....I Adults 0---0 N = 84 
<{ 80 
> 
> a: 60 :::l 
en 
I-
Z 40 
w 
U 
a: 
w 20 0... 
0 
0 6 12 18 24 36 48 60 
MONTHS 
Fig 4D-10.-The life survival of adults vs. Children using conventional immu· 
nosuppression. Note that the advantage in the pediatric patients was maintained 
throughout the first 5 years. (Used by permission.2<>j 
~tost of the 170 orthotopic }h·er recipients who were treated 
before March 1980 were given the triple-drug immunosuppres-
sive cocktail (see Fig 40-5) of azathioprine (or cyclophospha· 
mide), prednisone, and ALG. Almost two out of every three re-
cipients during this 17 -year period died before the end of the 
first postoperative year (Fig 40-9). Between ~farch 1980 and 
earlv November 1983, another 170 patients were treated, this 
tim~ with cyclosporine and corticosteroids as described in Chap-
ter 38. The overall results, pooling both adult and pediatric re-
cipients, were greatly improved (see Fig 40-9) in that two out of 
every three recipients now survh·ed for at least 12 months or, by 
actuarial analysis. are expected to survive. 
Conventional Immunosuppression 
Both in our early experience with con\·entional immuno-
suppression and subsequently. the results were better in the 
children than in adults. Of the 170 patients treated with conven-
tional immunosuppression between 1963 and 1980,86 were chil-
dren. Survival of the children was about 1O'7c better throughout 
the observation period (Fig 40-10). 
Fifty-three of the 86 childhood patients died within a year af-
ter transplantation under conventional immunosuppression. The 
causes of death were usually multiple. but a single most impor-
tant factor was usuallv identifiable (Table 40-3). Bacterial, fun-
gal. and viral infecti~ns were the main causes of death. There 
TABLE 4M-PK-~1Ky1:y CAI:SES OF DEATII 
WITHIN A YEAR ArrER LIYER TRA,\SPU:\T.\T10:\ 
AMONG 86 CHILDRE:-I " PRE-CYCLOSPORI:\E Ell\ 
Intra- and perioperativc death 
Technic-.lI surgical cumplicalion 
Unsatisfactory liver groUt 
Gmft rejection 
Infection 
Recurrent malignancy 
Other 
Total 
mocK·C"DCiEFpmEFol~cK ER.\ 
(86 C1I1I.DRF.") 
.1 
1.') 
1 
<I 
:20 
I 
2* 
:;'1 
·One died from pulmonary emboli at .52 days and an-
other from respiratory insufficiency resulting from all 
oversized graft. 
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were 9 deaths from abdominal sepsis, 5 from viral infection (ad-
enovirus, chickenpox. and herpes). 4 from systemic ba(:terial and 
fungal sepsis, and 2 from pulmonary infections, Tl'chnical surgi-
co.!l (.'omplications played a significant role. contributing to 15 
deaths (see Table 40-3), Eight of the 15 technical failures were 
of hiliarv duct reconstruction, and the other seven were of the 
vascular' anastomoses (4 hepatic artery, 3 portal w·in. and 1 su-
pr.lhepatic vena cava). 
The kind of data shown in Table 40-3 undoubtedly under-
states the role of rejection in the high rate of failure lll;der con-
ventional immunosuppression. Although irreversible rejection 
was only third as a cause of death, the enormous incidence of 
infectious complications reflected the necessity for excessh'e im-
munosuppression in order to maintain satisfactory function of the 
grafts. There was no margin of safety between a satisfactory ther-
apeutic level of immunosuppression and toxicity. 
The I-year actual survival of the 86 pediatric recipients in the 
pre-cyclosporine era is shown in Figure 40-11. The sur,i\'al of 
children with biliary atresia was substantially lower than that 
with other diseases, and it was markedlv inferior to that of chil-
dren treated for inborn metabolic errors". The poor survival with 
biliary atresia was partly due to the fact that previous major 
procedures, such as hepatic portoenterostomy, made the trans-
plant operations more difficult. In addition, anatomical anomalies 
such as hypoplastic, sclerotic, and sometimes thrombosed portal 
veins were more common in children with ad\'anced biliary 
atresia. 
Cyclosporine-Corticosteroid Therapy 
The survival expectations have greatly increased in patients 
whose immunosuppression has been with cyclosporine-cortico-
steroid therapy. DUring the last 4 years, 83 pediatric recipients 
have been treated, and. of these, almost three fourths are still 
alive. The actual survival of patients followed for at least 1 year 
and the actuarial projections of the much larger group shown in 
Figure 40-12 are similar, although the chances of survival have 
improved during the last year as will be noted later. The chil-
dren with biliary atresia have continued to fare less well than 
those with other hepatic diseases, and the superior results in 
inborn errors of metabolism noted in the pre-cyclosporine era 
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Fig .11.-infiuence of original liver disease on I-year survival under con-
ventional immunosuppression. (Used by permission,5) 
have continued. Death from infection has almost been elimi-
nated. 
Reduction of Perioperative Mortality 
Although the improvement in survival coincident with the in-
troduction of cyclosporine-corticosteroid therapy was encourag-
ing, the perioperative mortali~D continued to be unacceptable 
both in adults and children until relativelv recentlv. An assess-
ment in early 1983 of the reasons for th~ early ~ortaljty sug-
gested that many of the losses could be avoided by more effec-
tive dose control of cyclosporine and by more aggressive use of 
retransplantation. 
DOUBLE-RollTE Aa~ff:-;fpqoy11M:-D: OF CYCLOSPORI:'\E.-Since 
early 1983, cyc1osporine has been given intravenously as well as 
orally during the first few postoperative weeks, When pharma-
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Fig 4O-12.-Four·year aduaria! survival of pediatric liver 1ranspIant patients: CUMl} vs. survival of 83 dIiIdren under cydosporinlHX>rticosteroi therapy (ac-
SuMvaI 0/ 86 children treated with conventional immunosuppression (ac1uaI 1uaMI). 
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cologie monitoring of plasma and blood cydosporine levels be-
('".une standardized, it was realized that many of the liver recipi-
ents had poor absorption of the drug if it was given orally. 
especially during the critical 6rst several weeks. Co-nsequently, 
our practll.:e has become to give 6 mglkg cydosporine per day (2 
mg/kg every 8 hours) for about 2 weeks, or longer if necessary, 
nith a full additional dose of 17.5 m~g per day orally when diet 
is resumed. The level of blood cyclosporine has been monitored 
very carefully for the first se\'eral weeks to assure appropriate 
doses (Fig 40-13). The objective has been to reduce the inci-
dence of irreversible rejection and to diminish the need for spo-
radic or maintenance high-dose corticosteroid therapy. 
RETR-\NSPL-\NTAlloN.-The second adjustment has been to 
consider retransplantation at any time a recipienfs well-being is 
undermined by poor hepatic function. whatever the cause. The 
consequence has been an increased incidence of retransplanta-
tion (see Fig 40-3)_ 
The institution of the foregOing changes in management phi-
losophy has had a profound effect upon our program of transplan-
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Fig 40-13.-The administration of cyclosponne by the intravenous as well as 
by oral routes postoperatively. The objective was to maintain the blood cydo-
sporine as measured by high-performance liquid chromatography (HPLC) at 
about 300 nglml. The intravenous doses were decreased, and the oral doses 
were increased under the guidance of the monitoring. SGPT indicates serum 
glutamic pyruvic transaminase; SGOT. serum glutamic olCaloacelic transami-
nase; S.C., SoIu-Cortef; and S.M., SoIu-Medrol. 
TABLE 40-4.-PEDIATRIC 
P.-\l1ENTS TRE.-\TED coo~1 
~fAoC" I, 1983-ApRIL 1. 1984 
Patients 
Alive 
Dead 
36 
33- (9 1. 6'k ) 
3t 
-Eight after retransplantation. 
tOne after retranspiantation. 
tation in children. Beginning ~farch I, 1983, and ending in late 
~farch 1984, 36 patients have been treated with orthotopic liver 
transplantation. Thirty-three (91.6%) of these recipients are alive 
(Table 40-4). Of the 33 survivors, eight are alive by virtue of 
retransplantation. Two of these survivors have had two retrans-
plantations. If aggressive retransplantation had not been per-
formed, the present survival of this group of patients would have 
been less than 70%. 
The reasons for the 11 retransplantations in nine children are 
summarized in Table 40-5. Rejection was the leading cause of 
graft loss. Hepatic artery thrombosis was a close second. The 
hepatic artery thromboses have not necessarily represented tech-
nical errors, because in several instances the arteries have 
thrombosed as they originated from aortic grafts. which in turn 
were anastomosed to the recipient aorta. In experimental ani-
mals. rejection is associated \\ith low flow. 14 Thus, the underly-
ing factor may have been incomplete control of rejection. 
Age VS. Survival of the Child Recipient 
Iwatsuki et al.6 have studied the influence of age at the time 
of liver transplantation upon survival in a group of patients for 
whom at least 15 months follow-up was available. In the pre-
cyclospOljne era, 28 (53%) of 53 infants and preschool children 
(less than 6 years), 8 (50%) of 16 school-age children (between 6 
and 12 years), and 13 (76%) of 17 adolescents lived more than 3 
months (Fig 40-14). In the cvclosporine era, 16 (76%) of 21 in-
fants and preschool children. 8 (6i%) of 12 school-age children, 
and 6 (86%) of 7 adolescents lived more than 3 months (see Fig 
40-14). Thus. the 3-month survival of infants and preschool chil-
dren was similar to that of school-age children both in the pre-
cyclosporine era and the cyclosporine era. Five of seven (71 %) 
infants less than a year old lived more than 3 months. The tech-
nical difficulties in' infant surgery have been overcome in liver 
transplantation. The age of children should not be a considera-
tion in accepting them as candidates for liver transplantation. 
though liver donors for very small infants are quite scarce. 
The Place of Liver Transplantation 
in Pediatric Hepatology 
With the major improvements in patient survival that began 
in 1980, it was not surprising that a Consensus Development 
Conference held in 1983 in Bethesda. :'.Iarvland, came to the 
conclusion that liver tr.lnsplantation was a se~vice rather than an 
TABLE 40-5.-REASO:-;S FOR 
11 RETR.-\:\SI'L-\:"IT,-\110SS 1:-\ 
PEDIATRIC RECII'IE:-;rs 
(:'.I,-\RCII I, 19S3-AI'IIiL 1, 1984) 
Hejet:tion 
lIepatit: artery thrnmhosis 
lschemie liwr injury 
Liver injury after hemorrhage 
Total 
:=; 
.. 
I 
1 
11 
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Fig 4G-14.-Age distnbution of 126 childhood liver recipients. A shaded 
square represents a child who survived more than 3 months, and a black square 
represents a child who died within 3 months. All of the surviving patients treated 
with cyclosporine have follow-ups of at least 15 months. (Used by permission. "l 
"experimental" undertaking and was in fact the only meaningful 
service that could be offered for some diseases and under reason-
ablv clear circumstances. 12 
The positive Consensus Development Conference has opened 
the possibility of much broader funding for liver transplantation 
and for the establishment of an interconnecting series of centers 
in the United States that could share both organs and recipients. 
Our estimate is that 30 centers will be needed in the United 
States. The majority \\;11 serve both adults and the pediatric pop-
ulation. The need for only low doses of corticosteroids in patients 
treated with cyclosporine has allowed child recipients of various 
organs to grow and develop in a way not previously possible us-
ing conventional immunosuppression. 17 
We have within our grasp the means by which the practice of 
hepatology can be changed in the same way as became possible 
in nephrology with the development of renal transplantation. 
The exploitation of these advances will require regional trans· 
plantation centers. Procedures of marginal benefit such as portal 
diversion for variceal hemorrhage and repetitive biliary tract re-
constructions in diseases such as biliary atresia will become less 
common as it is appreciated that the final option of liver trans-
plantation can be severely jeopardized by earlier interventions. 
The use of liver transplantation for "metabolic engineering" 
will be a special feature of liver transplantation in pediatric hos-
pitals. The principle of permanently correcting hepatic-based in-
born errors of metabolism with liver transplantation has been 
validated. 
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